• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素可降低糖尿病大鼠尿液中N-乙酰-β-D-氨基葡萄糖苷酶、白蛋白及肾脏氧化标志物的排泄量。

Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.

作者信息

Oktem Faruk, Ozguner Fehmi, Yilmaz H Ramazan, Uz Efkan, Dündar Bumin

机构信息

Department of Pediatric Nephrology, School of Medicine, Suleyman Demirel University, Isparta, Turkey.

出版信息

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):95-101. doi: 10.1111/j.1440-1681.2006.04330.x.

DOI:10.1111/j.1440-1681.2006.04330.x
PMID:16445706
Abstract
  1. Increased oxidative stress has an important role in the pathogenesis of diabetic nephropathy. The aim of the present study was to evaluate diabetic nephropathy by determining markers of oxidative stress and the urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG), albumin and to investigate the possible protective effects of in vivo melatonin on renal tubular oxidative damage in diabetic rats. 2. Twenty-six rats were randomly divided into three groups: (i) group I, control, non-diabetic rats (n = 9); (ii) group II, untreated diabetic rats (n = 8); and (iii) group III, melatonin-treated diabetic rats (n = 9). In groups II and III, diabetes developed 3 days after administration of a single dose of streptozotocin (35 mg/kg, i.p.). Thereafter, whereas the rats in group II received no treatment, rats in group III began to receive 10 mg/kg per day, i.p., melatonin for 8 weeks. Malondialdehyde (MDA), an index of lipid peroxidation, NAG and microalbumin in the urine, markers of renal tubular damage, were the parameters used for oxidative stress-induced renal injury. Superoxide dismutase (SOD), xanthine oxidase (XO) and glutathione peroxidase (GSH-Px) activities were determined to evaluate changes in the anti-oxidant status of kidney tissue. 3. In untreated diabetic rats, urinary NAG, albumin and renal MDA levels were markedly increased compared with control rats (P < 0.0001). However, these parameters were reduced in diabetic rats by melatonin treatment (P < 0.0001). Urinary excretion of NAG was positively correlated with the microalbuminuria and renal MDA levels (r = 0.8; P < 0.0001). The SOD and XO activities in the untreated diabetic group were found to be significantly higher than those of the control group (P < 0.0001). Superoxide dismutase and XO activities decreased in melatonin-treated rats compared with untreated diabetic rats (P < 0.002 and P < 0.023, respectively). However, the decrease did reach levels seen in control rats. There were no significant differences in GSH-Px activity between the three groups. 4. Therefore, on the basis of these data, we suggest that urinary NAG, albumin excretion, XO activity and MDA levels are more valuable parameters showing the degree of renal tubular injury than classical markers of oxidative stress, including SOD and GSH-Px, in diabetic rat kidneys. Melatonin has an ameliorating effect on oxidative stress-induced renal tubular damage via its anti-oxidant properties. Thus, it may be suggested that urinary NAG excretion and microalbuminuria may be important markers showing the degree of renal changes and the success of long-term treatment of renal impairment with melatonin.
摘要
  1. 氧化应激增加在糖尿病肾病的发病机制中起重要作用。本研究的目的是通过测定氧化应激标志物以及N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)、白蛋白的尿排泄量来评估糖尿病肾病,并研究体内褪黑素对糖尿病大鼠肾小管氧化损伤的可能保护作用。2. 26只大鼠随机分为三组:(i)第一组,对照组,非糖尿病大鼠(n = 9);(ii)第二组,未治疗的糖尿病大鼠(n = 8);(iii)第三组,褪黑素治疗的糖尿病大鼠(n = 9)。在第二组和第三组中,单次腹腔注射链脲佐菌素(35 mg/kg)3天后诱发糖尿病。此后,第二组大鼠不接受治疗,而第三组大鼠开始每天腹腔注射10 mg/kg褪黑素,持续8周。丙二醛(MDA)作为脂质过氧化指标,尿中的NAG和微量白蛋白作为肾小管损伤标志物,是用于评估氧化应激诱导的肾损伤的参数。测定超氧化物歧化酶(SOD)、黄嘌呤氧化酶(XO)和谷胱甘肽过氧化物酶(GSH - Px)活性以评估肾组织抗氧化状态的变化。3. 与对照组大鼠相比,未治疗的糖尿病大鼠尿NAG、白蛋白和肾MDA水平显著升高(P < 0.0001)。然而,褪黑素治疗使糖尿病大鼠的这些参数降低(P < 0.0001)。尿NAG排泄与微量白蛋白尿和肾MDA水平呈正相关(r = 0.8;P < 0.0001)。未治疗的糖尿病组的SOD和XO活性显著高于对照组(P < 0.0001)。与未治疗的糖尿病大鼠相比,褪黑素治疗的大鼠SOD和XO活性降低(分别为P < 0.002和P < 0.023)。然而,降低幅度未达到对照组水平。三组之间GSH - Px活性无显著差异。4. 因此,基于这些数据,我们认为在糖尿病大鼠肾脏中,尿NAG、白蛋白排泄、XO活性和MDA水平是比包括SOD和GSH - Px在内的经典氧化应激标志物更有价值的显示肾小管损伤程度的参数。褪黑素通过其抗氧化特性对氧化应激诱导的肾小管损伤有改善作用。因此,可以认为尿NAG排泄和微量白蛋白尿可能是显示肾脏变化程度以及褪黑素长期治疗肾功能损害成功与否的重要标志物。

相似文献

1
Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.褪黑素可降低糖尿病大鼠尿液中N-乙酰-β-D-氨基葡萄糖苷酶、白蛋白及肾脏氧化标志物的排泄量。
Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):95-101. doi: 10.1111/j.1440-1681.2006.04330.x.
2
Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart.咖啡酸苯乙酯对糖尿病大鼠心脏脂质过氧化及抗氧化酶的影响。
Clin Biochem. 2005 Feb;38(2):191-6. doi: 10.1016/j.clinbiochem.2004.10.003.
3
Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus.褪黑素治疗糖尿病中肾缺血再灌注损伤诱导的远隔器官损伤。
Arch Pharm Res. 2008 Jun;31(6):705-12. doi: 10.1007/s12272-001-1216-3. Epub 2008 Jun 19.
4
Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats.褪黑素对链脲佐菌素诱导的糖尿病大鼠组织氧化-抗氧化状态的影响。
Cell Biochem Funct. 2003 Jun;21(2):121-5. doi: 10.1002/cbf.1006.
5
Diltiazem attenuates oxidative stress in diabetic rats.地尔硫卓减轻糖尿病大鼠的氧化应激。
Ren Fail. 2005;27(3):335-44.
6
Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis.褪黑素对链脲佐菌素诱导的糖尿病大鼠睾丸脂质过氧化和抗氧化酶的影响。
Asian J Androl. 2006 Sep;8(5):595-600. doi: 10.1111/j.1745-7262.2006.00177.x. Epub 2006 Jun 5.
7
Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver.咖啡酸苯乙酯(CAPE)对糖尿病大鼠肝脏脂质过氧化和抗氧化酶的保护作用。
J Biochem Mol Toxicol. 2004;18(4):234-8. doi: 10.1002/jbt.20028.
8
Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats.褪黑素可改善大鼠慢性肾衰竭引起的氧化性器官损伤。
J Pineal Res. 2004 May;36(4):232-41. doi: 10.1111/j.1600-079X.2004.00113.x.
9
[Renal protective effects of sulodexide in diabetic rats and its anti-oxidative mechanism].舒洛地昔对糖尿病大鼠的肾脏保护作用及其抗氧化机制
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Apr;29(4):778-80.
10
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.体内证据表明氧化应激在万古霉素诱导的肾毒性发病机制中的作用:厄多司坦的保护作用。
Toxicology. 2005 Nov 15;215(3):227-33. doi: 10.1016/j.tox.2005.07.009. Epub 2005 Aug 19.

引用本文的文献

1
Rs4862705 in the melatonin receptor 1A gene is associated with renal function decline in type 1 diabetes individuals.褪黑素受体 1A 基因中的 rs4862705 与 1 型糖尿病个体的肾功能下降相关。
Front Endocrinol (Lausanne). 2024 Mar 14;15:1331012. doi: 10.3389/fendo.2024.1331012. eCollection 2024.
2
Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.褪黑素对糖尿病相关肾脏损伤动物模型的肾脏保护作用:系统评价和荟萃分析。
J Diabetes Res. 2022 Jun 14;2022:3770417. doi: 10.1155/2022/3770417. eCollection 2022.
3
Mitochondrial Oxidative Stress and Cell Death in Podocytopathies.
足细胞病变中的线粒体氧化应激和细胞死亡。
Biomolecules. 2022 Mar 4;12(3):403. doi: 10.3390/biom12030403.
4
Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus.褪黑素作为一种时间生物学剂和细胞保护剂在糖尿病中的治疗潜力。
J Diabetes Metab Disord. 2020 Jul 21;19(2):1797-1825. doi: 10.1007/s40200-020-00585-2. eCollection 2020 Dec.
5
Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice.钠-葡萄糖协同转运蛋白 2 抑制剂改善肥胖小鼠肾脏近端小管细胞自噬流障碍。
Int J Mol Sci. 2020 Jun 5;21(11):4054. doi: 10.3390/ijms21114054.
6
Melatonin: new insights on its therapeutic properties in diabetic complications.褪黑素:关于其在糖尿病并发症中治疗特性的新见解。
Diabetol Metab Syndr. 2020 Apr 8;12:30. doi: 10.1186/s13098-020-00537-z. eCollection 2020.
7
Oxidative-antioxidative status and hepatic and renal factors following melatonin administration in castrated and intact dogs.褪黑素给药后去势和未去势犬的氧化-抗氧化状态及肝脏和肾脏因素
Basic Clin Androl. 2019 Nov 15;29:14. doi: 10.1186/s12610-019-0094-6. eCollection 2019.
8
Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice.奥美沙坦酯,一种血管紧张素 II 受体阻滞剂,可改善 db/db 小鼠的肾损伤。
Drug Des Devel Ther. 2019 Oct 22;13:3657-3667. doi: 10.2147/DDDT.S217826. eCollection 2019.
9
Renoprotective effects of olmesartan medoxomil on diabetic nephropathy in streptozotocin-induced diabetes in rats.奥美沙坦酯对链脲佐菌素诱导的糖尿病大鼠糖尿病肾病的肾脏保护作用。
Biomed Rep. 2014 Jan;2(1):24-28. doi: 10.3892/br.2013.183. Epub 2013 Oct 9.
10
Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice.db/db 小鼠肾脏线粒体中线粒体复合物 III 功能障碍和褪黑素反应性活性氧生成。
J Pineal Res. 2011 Oct;51(3):338-44. doi: 10.1111/j.1600-079X.2011.00894.x. Epub 2011 May 27.